These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
399 related items for PubMed ID: 11584850
1. Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca. Iester M, Orsoni GJ, Gamba G, Taffara M, Mangiafico P, Giuffrida S, Rolando M. Eye (Lond); 2000 Dec; 14(Pt 6):892-8. PubMed ID: 11584850 [Abstract] [Full Text] [Related]
2. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. Lee HK, Ryu IH, Seo KY, Hong S, Kim HC, Kim EK. Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211 [Abstract] [Full Text] [Related]
3. Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study. Troiano P, Monaco G. Cornea; 2008 Dec; 27(10):1126-30. PubMed ID: 19034126 [Abstract] [Full Text] [Related]
4. Tear film osmolarity measurements in dry eye disease using electrical impedance technology. Jacobi C, Jacobi A, Kruse FE, Cursiefen C. Cornea; 2011 Dec; 30(12):1289-92. PubMed ID: 22001814 [Abstract] [Full Text] [Related]
6. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin. Karalezli A, Borazan M, Altinors DD, Dursun R, Kiyici H, Akova YA. Cornea; 2009 Jan; 28(1):46-50. PubMed ID: 19092405 [Abstract] [Full Text] [Related]
7. Effectiveness of artificial tears in the management of evaporative dry eye. McCann LC, Tomlinson A, Pearce EI, Papa V. Cornea; 2012 Jan; 31(1):1-5. PubMed ID: 21968605 [Abstract] [Full Text] [Related]
8. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease. Lee HS, Ji YS, Yoon KC. Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018 [Abstract] [Full Text] [Related]
9. Autologous serum eyedrops in the treatment of aniridic keratopathy. López-García JS, Rivas L, García-Lozano I, Murube J. Ophthalmology; 2008 Feb; 115(2):262-7. PubMed ID: 17675158 [Abstract] [Full Text] [Related]
10. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, Bartels SP, Micuda T, Proskin HM, Vogel R. Am J Ophthalmol; 2004 Sep; 138(3):444-57. PubMed ID: 15364229 [Abstract] [Full Text] [Related]
11. Alterations of the ocular surface epithelial mucins 1, 2, 4 and the tear functions in patients with atopic keratoconjunctivitis. Dogru M, Okada N, Asano-Kato N, Igarashi A, Fukagawa K, Shimazaki J, Tsubota K, Fujishima H. Clin Exp Allergy; 2006 Dec; 36(12):1556-65. PubMed ID: 17177679 [Abstract] [Full Text] [Related]
12. A mouse model of keratoconjunctivitis sicca. Dursun D, Wang M, Monroy D, Li DQ, Lokeshwar BL, Stern ME, Pflugfelder SC. Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):632-8. PubMed ID: 11867577 [Abstract] [Full Text] [Related]
13. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. Berdoulay A, English RV, Nadelstein B. Vet Ophthalmol; 2005 Mar; 8(4):225-32. PubMed ID: 16008701 [Abstract] [Full Text] [Related]
14. Conjunctival impression cytology and tear-film changes in patients with familial Mediterranean fever. Karalezli A, Borazan M, Yilmaz S, Kiyici H, Akova YA. Acta Ophthalmol; 2009 Feb; 87(1):39-43. PubMed ID: 19094172 [Abstract] [Full Text] [Related]
15. [Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca]. Schrell C, Cursiefen C, Kruse F, Jacobi C. Klin Monbl Augenheilkd; 2012 May; 229(5):548-53. PubMed ID: 22189827 [Abstract] [Full Text] [Related]
16. Tear film osmolarity in patients treated for glaucoma or ocular hypertension. Labbé A, Terry O, Brasnu E, Van Went C, Baudouin C. Cornea; 2012 Sep; 31(9):994-9. PubMed ID: 22710490 [Abstract] [Full Text] [Related]
17. [Impression cytology contribution to differential diagnosis of Sjögren syndrome in the ophthalmological clinic]. Rivas L, Murube J, Shalaby O, Oroza MA, Sanz AI. Arch Soc Esp Oftalmol; 2002 Feb; 77(2):63-72. PubMed ID: 11854857 [Abstract] [Full Text] [Related]
18. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Wang Y, Ogawa Y, Dogru M, Kawai M, Tatematsu Y, Uchino M, Okada N, Igarashi A, Kujira A, Fujishima H, Okamoto S, Shimazaki J, Tsubota K. Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500 [Abstract] [Full Text] [Related]
19. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops. Hwang HS, Sung YM, Lee WS, Kim EC. Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152 [Abstract] [Full Text] [Related]
20. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits. Parrilha LR, Nai GA, Giuffrida R, Barbero RC, Padovani LD, Pereira RH, Silva DA, Silva MC, Diniz MS, Andrade SF. Arq Bras Oftalmol; 2015 Sep; 78(5):295-9. PubMed ID: 26466228 [Abstract] [Full Text] [Related] Page: [Next] [New Search]